Paper Details
- Home
- Paper Details
Drug interaction study between bupropion and ticlopidine in male CF-1 mice.
Author: HassanHazem EmadEldin, MoellerBryant Michael, MolnariJillissa Christine, MyersAlan Lewis
Original Abstract of the Article :
Bupropion is an atypical antidepressant that is biotransformed in humans to its major active metabolite hydroxybupropion by cytochrome P450 2B6 (CYP2B6). Co-administration of bupropion with an inhibitor of CYP2B6 can result in a serious drug interaction, leading to bupropion related adverse effects ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1248/bpb.34.447
データ提供:米国国立医学図書館(NLM)
Bupropion and Ticlopidine: A Drug Interaction in the Desert
This study investigates a potential drug interaction between bupropion, an antidepressant, and ticlopidine, an antiplatelet agent, in mice. Bupropion is metabolized by an enzyme called CYP2B6, and ticlopidine can inhibit this enzyme, potentially leading to increased levels of bupropion in the body. The researchers found that co-administering bupropion and ticlopidine in mice resulted in significantly higher bupropion levels, suggesting a potential for drug interactions in humans. This research underscores the importance of considering potential drug interactions when prescribing medications.Drug Interactions: A Desert of Unexpected Encounters
The study's findings highlight the potential for drug interactions between bupropion and ticlopidine, two medications commonly used to treat different conditions. This research serves as a reminder that medications can interact in complex ways, and it's crucial for healthcare professionals to be aware of these potential interactions to ensure patient safety. The desert of drug interactions can be full of unexpected encounters, and careful navigation is essential for optimal health.Medication Safety: A Journey Through the Desert
This study underscores the importance of discussing medication history with healthcare providers to ensure medication safety. The findings highlight the potential for drug interactions between bupropion and ticlopidine, emphasizing the importance of considering potential interactions when prescribing medications. This research reminds us that the desert of medication can be challenging, but with careful navigation and communication, we can ensure a safe and effective journey.Dr.Camel's Conclusion
This study investigates a potential drug interaction between bupropion and ticlopidine in mice. The findings suggest a potential for drug interactions between these medications in humans, highlighting the importance of considering potential interactions when prescribing medications.Date :
- Date Completed 2011-11-22
- Date Revised 2019-07-20
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.